We are live on ! Find out more
BOUT icon

CapForce IBD Breakout Opportunities ETF

5 hedge funds and large institutions have $4.09M invested in CapForce IBD Breakout Opportunities ETF in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

47.84% more ownership

Funds ownership: 0%47.84% (+48%)

Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
$2.2M +$2.2M +89,079 New
AIP
2
Ahrens Investment Partners
Louisiana
$826K +$825K +33,470 New
LTFS
3
Ladenburg Thalmann Financial Services
Florida
$610K +$610K +24,730 New
Janney Montgomery Scott
4
Janney Montgomery Scott
Pennsylvania
$325K +$325K +13,187 New
CPIG
5
Chicago Partners Investment Group
Illinois
$136K +$172K +6,976 New

BOUT Hedge Fund Activity: Q3 2018 in Review

5 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q3 2018, worth a combined $4.09M.

Buyers outnumbered sellers: 5 funds opened new BOUT positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $2.2M.

  • 5 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q3 2018, up from 0 in Q2 2018.
  • Funds reported $4.09M of CapForce IBD Breakout Opportunities ETF stock for Q3 2018.
  • 5 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q3 2018 and 0 closed out, a net change of +5 holders.
  • The largest CapForce IBD Breakout Opportunities ETF buyer in Q3 2018 was Jane Street, an estimated $2.2M added.

Based on aggregated 13F filings for Q3 2018.